 |
|
|
|
 |
|
|
| Article 1 to 8 out of 8 concerning Patheon Inc.
|
-
Patheon Announces Expansion of Manati Puerto Rico Facility for High Potency Manufacturing
(06/13/2008)
Patheon Inc. announced it will expand the Manati, Puerto Rico facility to add a dedicated high potency and controlled substance manufacturing area. Patheon will invest a total of $2.8 million in this new 3,386ft(2) area that will include three ...
-
Patheon Announces Japanese Subsidiary Patheon, K.K.
(06/06/2008)
Patheon Inc. announced the establishment of a Japanese subsidiary based in Tokyo, Japan. Patheon K.K. will operate from a newly established business office located in the Nihonbashi district of central Tokyo and will support Patheon's business ...
-
Patheon completes York Mills facility sale
(04/22/2008)
Patheon announced the completion of the sale of its York Mills facility located in Toronto, Canada for CDN$12.5 million (US$12.3 million) effective April 15, 2008.The agreement to sell the facility for a purchase price of CDN$12.5 million (US$12.3 ...
-
Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
(03/25/2008)
Acquires Rights from UCSD to Develop Cysteamine for the Treatment of NASH
Raptor Pharmaceuticals Corp. announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc., has acquired an exclusive worldwide license to intellectual property from the University of California, San Diego ("UCSD") around the use of ...
-
Patheon Announces Executive Management Changes
(02/21/2008)
Patheon Inc. announced changes in the roles of several of the Company's senior executives.Nick DiPietro will be assuming a new role as Executive Vice-President, Corporate Development and, accordingly, will relinquish his responsibilities as ...
-
Patheon Announces Agreement to Sell Niagara-Burlington Manufacturing Business
(12/07/2007)
Patheon Inc. announced that it has entered into a definitive agreement to sell its Niagara-Burlington commercial manufacturing business to Pharmetics Inc. Based in Laval, Quebec, Pharmetics is a privately owned contract manufacturer of vitamins, ...
-
Patheon Announces Appointment of Riccardo Trecroce as Chief Executive Officer
(04/02/2007)
Patheon announced that the appointment of Riccardo Trecroce as Chief Executive Officer of Patheon Inc. has been confirmed for an indefinite period. Mr. Trecroce was initially appointed as Chief Executive Officer for an interim period in September ...
-
Merck & Co., Inc. Selects Patheon as Strategic Supplier
(01/31/2006)
Patheon Inc. announced that Patheon has entered into a five-year master supply agreement with Merck & Co., Inc. to provide commercial manufacturing and pharmaceutical development services to Merck, and that Merck has selected Patheon as one of ...
Additional information
Patheon Inc.
Mississauga, ON, Canada
Company
|
|
|
|
|
|
Top
